Summary
Nonbinding resource describing regulatory considerations for AI in health across the product lifecycle. Addresses data quality, risk management, transparency, post‑market monitoring, and international cooperation.
Healthcare Implications
Manufacturers and regulators can use this as a checklist when designing oversight for AI‑enabled health technologies. Hospitals should anticipate documentation needs for procurement and clinical governance.